Medical cannabis: Another piece in the mosaic of autoimmunity?
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Legalization of cannabis' medicinal use is rapidly increasing worldwide, raising the need to evaluate medical implications of cannabis. Currently, evidence supports cannabis and its active ingredients as immune‐modulating agents, affecting T‐cells, B‐cells, monocytes, and microglia cells, causing an overall reduction in pro‐inflammatory cytokine expression and an increase in anti‐inflammatory cytokines. Due to the supporting evidence of cannabinoids as an immune‐modulating agent, research focusing on cannabinoids and autoimmunity has emerged. Several clinical trials in multiple sclerosis, inflammatory bowel disease, and fibromyalgia suggest cannabis' effectiveness as an immune‐modulator. However, contradicting results and lack of large‐scale clinical trials obscure these results. Although lacking clinical research, in vitro and in vivo experiments in rheumatoid arthritis, diabetes type 1, and systemic sclerosis demonstrate a correlation between disease activity and cannabinoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Gunn, J. K. L., Rosales, C. B., Center, K. E., Nuñez, A., Gibson, S. J., Christ, C., & Ehiri, J. E. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009986 · Cited by 576
Nabilone for the treatment of pain in fibromyalgia.
Skrabek, R. Q., Galimova, L., Ethans, K., & Perry, D. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.002 · Cited by 384 · cited 1×
“A study comprised of 40 patients with fibromyalgia was able to demonstrate pain relief, reduction in anxiety, and decrease in the Fibromyalgia Impact Questionnaire score following Nabilone treatment.(58) Additionally, Nabilone was found to have a beneficial effect on sleep, superior to that of amitriptyline, yet witho…”
BackgroundAdverse effects of medical cannabinoids: a systematic review
Wang, T., Collet, J.-P., Shapiro, S., & Ware, M. A. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071178 · Cited by 357
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c76f70 · Cited by 324
Richardson, D., Pearson, R. G., Kurian, N., Latif, M. L., Garle, M. J., Barrett, D. A., Kendall, D. A., Scammell, B. E., Reeve, A. J., & Chapman, V. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2401 · Cited by 303 · cited 2×
“Additionally, evidence for CB1R and CB2R expression in synovia cells was also found.(33) Further examination and cultivation of synovial cells, derived from patients with RA by two other different groups revealed that cannabinoid-based therapy could attenuate IL-6, IL-8, and matrix metalloproteinase-3 production.”
BackgroundCannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
Fukuda, S., Kohsaka, H., Takayasu, A., Yokoyama, W., Miyabe, C., Miyabe, Y., Harigai, M., Miyasaka, N., & Nanki, T. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-275 · Cited by 93 · cited 1×
“Further examination and cultivation of synovial cells, derived from patients with RA by two other different groups revealed that cannabinoid-based therapy could attenuate IL-6, IL-8, and matrix metalloproteinase-3 production.(34,35) Supporting the human-based finding mentioned above, murine-based models indicate not o…”
BackgroundCannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
Garcia-Gonzalez, E., Selvi, E., Balistreri, E., Lorenzini, S., Maggio, R., Natale, M.-R., Capecchi, P.-L., Lazzerini, P.-E., Bardelli, M., Laghi-Pasini, F., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/kep189 · Cited by 63 · cited 1×
“The patients with SSc skin biopsies exposed to WIN55,212-2 (CB1 and CB2 agonist) correlate with reduced extracellular matrix disposition, decreased myofibroblasts differentiation, and resistance to apoptosis.(56) Considering the deleterious effect of SSc and lack of successful therapy, the supporting evidence advocate…”
BackgroundGui, H., Liu, X., Liu, L.-R., Su, D.-F., & Dai, S.-M. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.12.012 · Cited by 60 · cited 1×
“Treated mice presented clinical improvement, which was manifested as a decrease in joint swelling and destruction, synovial inflammation, and serum levels of anticollagen II antibodies.(37) Currently, although data consistently show the beneficial effect of cannabinoids in RA murine models and in vitro experiments, cl…”
BackgroundLowin, T., Pongratz, G., & Straub, R. H. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0114-7 · Cited by 52 · cited 1×
“Further examination and cultivation of synovial cells, derived from patients with RA by two other different groups revealed that cannabinoid-based therapy could attenuate IL-6, IL-8, and matrix metalloproteinase-3 production.(34,35) Supporting the human-based finding mentioned above, murine-based models indicate not o…”
BackgroundHU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid
Haj, C. G., Sumariwalla, P. F., Hanuš, L., Kogan, N. M., Yektin, Z., Mechoulam, R., Feldmann, M., & Gallily, R. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226100 · Cited by 26
Cited by
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Cooper, Z. D., & Craft, R. M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.140 · Cited by 350
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
T Cell Subpopulations in the Physiopathology of Fibromyalgia: Evidence and Perspectives
Banfi, G., Diani, M., Pigatto, P. D., & Reali, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041186 · Cited by 46
Inflammation, Autoimmunity, and Infection in Fibromyalgia: A Narrative Review
Paroli, M., Gioia, C., Accapezzato, D., & Caccavale, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115922 · Cited by 42
“…been shown to modulate cytokine production by T lymphocytes, thus suggesting that their analgesic effect is at least in part mediated by adaptive immunity, specifically through inhibition of pro-inflammatory cytokine production and stimulation of those with anti-inflammatory activity [101,102].”
Background
Metadata
- Authors
- Katz, D., Katz, I., Porat‐Katz, B., & Shoenfeld, Y.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2016-12-20
- Volume
- 101
- Issue
- 2
- Pages
- 230-238
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2551539800
- Cited by
- 41
- References
- 13
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.